Preventing Kidney Damage from Cisplatin with Dithiocarbamates
Author Information
Author(s): L.V. Reznik, E.M. Myazinal, E.I. Shakchmatova, S.P. Gambaryan, V.K. Brovtsyn, Y.V. Natochin, M.M. Jones
Primary Institution: Sechenov Institute of Evolutionary Physiology and Biochemistry of the USSR Academy of Sciences and Vanderbilt University
Hypothesis
Can hydroxyl-containing dithiocarbamates prevent renal dysfunction caused by cisplatin in rats?
Conclusion
The study found that sodium N-methyl-D-glucamine dithiocarbamate (NaG) effectively prevents renal dysfunction caused by cisplatin in rats.
Supporting Evidence
- NaG treatment fully prevented the reduction of glomerular filtration rate (GFR) caused by cisplatin.
- NaY was less effective than NaG in preventing renal dysfunction.
- Cisplatin treatment resulted in a significant increase in serum creatinine and urea levels, which were normalized by NaG.
- NaG treatment maintained ionic homeostasis better than NaY after cisplatin administration.
Takeaway
This study shows that a special chemical can help protect rat kidneys from damage caused by a cancer drug.
Methodology
Female Wistar rats were injected with cisplatin and treated with dithiocarbamates to assess renal function through various biochemical measurements.
Limitations
The study was conducted only on rats, which may not fully represent human responses.
Participant Demographics
Female Wistar rats weighing between 140-160 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website